Shares of pharmacy benefit managers extended losses Tuesday after Pfizer Inc. Chief Executive Officer Albert Bourla said ...

So when vaccine skeptic Robert F. Kennedy Jr. was offered the top job at the Department of Health and Human Services, Pfizer ...

President-elect was happy that "he and his program [Operation Warp Speed] contributed significantly," to vaccine development, ...

Pfizer Inc. forecast 2025 sales and earnings in line with analysts’ projections, a step toward fending off an activist ...

Pfizer said Tuesday it does not expect the Trump administration to make major changes to vaccine policy next year even with ...

Pfizer is fending off investors’ fears about threats to its vaccine business under the Trump administration.

Shares of Pharmacy-benefit managers (PBMs) including CVS Health Corp (NYSE:CVS), UnitedHealth Group Inc (NYSE:UNH) and Cigna ...

The Vyndaqel family of drugs for the treatment of transthyretin amyloid cardiomyopathy is Pfizer’s fourth top-selling product ...

Revenue in 2025 will be $61 billion to $64 billion, Pfizer said, in line with predictions by Wall Street analysts.

Shares of pharmacy benefit managers extended losses Tuesday after Pfizer CEO Albert Bourla said President-elect Donald Trump ...

( MENAFN - Baystreet) Shares in health Insurers fell again. On Tuesday, Pfizer's (PFE) CEO, Albert Bourla, revealed that ...

Shares of UnitedHealth (NYSE:UNH) and CVS Health (NYSE:CVS) continued to trade lower on Tuesday after Pfizer (NYSE:PFE) CEO ...